网站主页 >> CAS数据库列表 >> 4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸
4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸
|
|
|
- CAS号:
- 344897-95-6
- 英文名:
- Leukadherin 1
- 英文别名:
- CS-2237;eukadherin-1;Leukadherin-1;Leukadherin 1;Leukadhedrin 1;LA1(Leukadherin-1);LEUKADHERIN 1;LEUKADHERIN1;4-(5-((3-Benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid;4-[5-[[4-Oxo-3-(phenylmethyl)-2-thioxo-5-thiazolidinylidene]methyl]-2-furanyl]-benzoic acid;Benzoic acid, 4-[5-[[4-oxo-3-(phenylmethyl)-2-thioxo-5-thiazolidinylidene]methyl]-2-furanyl]-
- 中文名:
- 4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸
- 中文别名:
- 白细胞粘附素-1;4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸
- CBNumber:
- CB52667990
- 分子式:
- C22H15NO4S2
- 分子量:
- 421.49
- MOL File:
- 344897-95-6.mol
|
|
|
4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸化学性质
-
沸点:
-
634.7±65.0 °C(Predicted)
-
|
-
密度:
-
1.50±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Sealed in dry,2-8°C
-
|
-
溶解度:
-
DMSO: soluble3mg/mL, clear (warmed)
-
|
-
酸度系数(pKa):
-
4.11±0.10(Predicted)
-
|
-
形态:
-
powder
-
|
-
颜色:
-
, yellow to orange to brown
-
|
4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸性质、用途与生产工艺
Leukadherin-1 是特异性的白细胞表面整合素 CD11b/CD18 的激动剂。Leukadherin-1 可增加 CD11b/CD18 依赖性细胞对血纤蛋白原的粘附，EC50为 4 μM。Leukadherin-1 增强白细胞对配体 (如 ICAM-1) 和血管内皮的粘附，从而减少白细胞跨内皮迁移和流入损伤部位。Leukadherin-1 抑制先天性炎症信号转导。
Leukadherin-1 is a specific agonist of the leukocyte surface integrin CD11b/CD18 (αMβ2; CR3; Mac-1). Leukadherin‐1 pretreatment reduces secretion of interferon (IFN)‐γ, tumour necrosis factor (TNF) and macrophage inflammatory protein (MIP)‐1β by monokine‐stimulated NK cells. Leukadherin‐1 pretreatment also reduces secretion of IL‐1β, IL‐6 and TNF by Toll‐like receptor (TLR)‐2 and TLR‐7/8‐stimulated monocytes.
Leukadherin-1 (1 mg/kg; i.p.; twice daily for 14 days) is beneficial in preventing hyperoxia-induced neonatal lung injury, an experimental model of bronchopulmonary dysplasia (BPD).
|
Animal Model:
|
Newborn Sprague Dawley rat pups
|
|
Dosage:
|
1 mg/kg
|
|
Administration:
|
I.p.; twice daily for 14 days
|
|
Result:
|
Beneficial on preventing the lung inflammatory response, improved alveolarization and vascular development, and reduced pulmonary vascular remodeling and PH in a hyperoxia-induced experimental model of BPD.
|
4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/01/25 | HY-15701 | 4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸
Leukadherin-1 | 344897-95-6 | 5 mg | 450元 |
| 2024/01/25 | HY-15701 | 4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸
Leukadherin-1 | 344897-95-6 | 10mM * 1mLin DMSO | 495元 |
4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸
生产厂家
344897-95-6, 4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸 相关搜索:
- API
- 药靶配体
- C22H15NO4S2
- 白细胞粘附素-1
- 4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸
- 344897-95-6
- 4-(5-((3-Benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid[Leukadherin1
- 4-(5-((3-Benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid
- Benzoic acid, 4-[5-[[4-oxo-3-(phenylmethyl)-2-thioxo-5-thiazolidinylidene]methyl]-2-furanyl]-
- eukadherin-1
- LEUKADHERIN 1;LEUKADHERIN1
- CS-2237
- LA1(Leukadherin-1)
- Leukadhedrin 1
- 4-[5-[[4-Oxo-3-(phenylmethyl)-2-thioxo-5-thiazolidinylidene]methyl]-2-furanyl]-benzoic acid
- Leukadherin-1
- Leukadherin 1